| Trial ID: | L3530 |
| Source ID: | NCT01048268
|
| Associated Drug: |
Glucose-Dependent Insulinotropic Polypeptide
|
| Title: |
Glucose-dependent Insulinotropic Polypeptide - New Role as Blood Glucose Stabilizer?
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus
|
| Interventions: |
DRUG: glucose-dependent insulinotropic polypeptide|DRUG: Placebo
|
| Outcome Measures: |
Primary: The difference in glucagon secretion quantified as the difference in plasma glucagon concentration and incremental baseline-subtracted area under the curve (AUC) for plasma glucagon, -10, 0, 5, 10, 20, 30, 45, 60 and 90 minutes at each visit | Secondary: The difference between the amount of infused glucose and the insulin responses, will be measured at each visit
|
| Sponsor/Collaborators: |
Sponsor: University Hospital, Gentofte, Copenhagen
|
| Gender: |
MALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1|PHASE2
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2009-12
|
| Completion Date: |
2014-04
|
| Results First Posted: |
|
| Last Update Posted: |
2015-07-14
|
| Locations: |
Department of Internal Medicine F' laboratory, Hellerup, Copenhagen County, 2900, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT01048268
|
